about
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells.Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs)In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cellsSIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptorGPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells.GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts.GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor.G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells.Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells.The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells.Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells.Differential expression of estrogen receptors (ERalpha/ERbeta) in testis of mature and immature pigs.The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer.The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs).Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function.Recent Advances on the Role of microRNAs in both Insulin Resistance and Cancer.miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)Prostasomes as zinc ligands in human seminal plasmaFocal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cellsDifferential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast TumorsGPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor ProgressionValproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival
P50
Q27322202-67B97B6A-A4CA-4D61-BFA5-E5BF7443DCB3Q34314290-0863AB89-D4D8-495C-A5F1-037BC86A6F38Q34458590-26B480F8-F874-4BD3-B8AD-A1689C8FD8BBQ35153546-AB805E5B-EEE8-49E8-8792-4C555322C5FAQ35786199-638D7FBC-F8A7-42E3-BCC5-1095722D5842Q36140873-88557395-F295-43F1-8DDF-2C17BDBB3974Q36274172-532EB622-E204-4D13-AA7C-F067E29B6B4CQ36293908-208364C8-7023-44C7-89F0-E1746531360EQ36445127-055B7764-0F4B-43ED-BD76-5A22E1CCE69EQ37022250-1A3801C6-B8D7-452F-91A0-A7816C34E5E8Q38762482-D5515415-CC73-4ED4-BC11-1E2F8E6D0B01Q38816699-69D5A7AE-A415-4D3B-BECA-9C2B92D9D11CQ38976445-9DC84DA9-A633-42EB-B90D-215D8DB217E2Q39432208-B93E0311-ACC3-48CE-9C7D-EC964FC0FDD9Q39626598-18CDB8BE-0445-4D4D-9350-A0560812BB1BQ39826396-AEC6020B-813E-4A7F-8C3D-A772FD38628DQ40169554-B28F2530-DDD9-4067-A2E1-E99C10628E58Q40256550-4E0C6AA1-4F33-4B02-B8E8-49CA06BD5552Q40550442-9D1ECF97-8D33-4990-8117-AB9149B622EBQ40593846-AB930157-6A40-466E-804B-D64795588ED4Q40601612-98B80C30-F56D-47CD-B62D-E924390A0939Q44088360-24104E23-B85D-49FF-B6B1-7DAF424778EEQ44187709-FCE4E7DD-5DC9-4C0C-A0D1-0778BC92E3E8Q44317859-C01EE2F6-D27E-4BC9-A4F0-D35B4754EBCCQ45130752-7A4E97E8-3ED7-4360-9717-BB52799F2414Q46765825-7A4EF74F-2AC8-483B-A1F3-E5994C1F6643Q47227722-16F10417-4C65-408A-B79D-521D37CDA5BFQ50925506-311AAA35-C91D-4309-9948-D76821DC6F5BQ50946013-F9C27CEC-F9BB-4E02-936D-809E03FFE17DQ53202423-AC4B2959-2C04-4D1E-B235-407D4D16CC80Q55340090-260028D5-33EC-4AE3-AB43-6A3B8F16A727Q59793155-FB737DB9-8A23-4D40-A247-76BB01A43B73Q60287209-0C90ED81-AE44-43F2-B14F-144EE0B5DD2AQ61798865-B3AEAA7C-BDC3-4C21-A7B4-9160D79CF7D1Q64058279-A29AC11A-688E-4CF1-AC5F-B9D2926D6541Q64119899-D3262A57-91F5-488A-972A-BE63B3D9E464Q92460558-36E51E43-D2C3-4272-B750-C99B343BCA2A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Adele Vivacqua
@ast
Adele Vivacqua
@en
Adele Vivacqua
@es
Adele Vivacqua
@nl
type
label
Adele Vivacqua
@ast
Adele Vivacqua
@en
Adele Vivacqua
@es
Adele Vivacqua
@nl
prefLabel
Adele Vivacqua
@ast
Adele Vivacqua
@en
Adele Vivacqua
@es
Adele Vivacqua
@nl
P106
P1153
6602884175
P21
P214
6691155044881672520007
P31
P496
0000-0001-5333-8396
P7859
viaf-6691155044881672520007